Seeking Patients and Caregivers of Those Diagnosed With  Chronic Myeloid Leukemia (CML) for Paid Study


We are seeking a limited number Patients and Caregivers of Newly diagnosed and those who have experience with Chronic Myeloid Leukemia (CML) for an online and telephone interview paid study.  Make up to $325.00 for 90 mins of time depending on which method you and your caregiver qualify for.


  • Patient must be diagnosed with Chronic Myelogenous (Myeloid) Leukemia (CML)
  • Patient must be actively receiving treatment for CML 
  • Patient must have access to high-speed internet.

If you do not meet the above criteria you will not be selected for this study, but we STILL want to hear from you! Please join our patient panel by CLICKING HERE

Who Are We (Echo Project Management Group, Inc.)

  • We are a leader in connecting patients with recognized medical Research Studies
  • We are dedicated to being up front and open with you. If you have questions just ask!
  • We are committed to protecting your personal data and are a HIPAA Compliant Entity

Patients and Caregivers Will be Compensated for Their Time

If you meet the above qualifications we want to hear from you!

Please enter the requested information below and you will be contacted by one of our representatives


** We ask that you please honor the commitment to participate in this research study you are signing up for and please return all communications from Echo PMG.  Your opinion is very IMPORTANT and truly matters and it is the only way we can further the treatment of any and all medical conditions.  WE ALL COUNT ON YOU!

We (ECHO PMG) will comply with all US laws in protecting your personal data, and also in accordance with BHBIA guidelines and the MRS/EphMRA, PBIRG and ABPI codes of conduct.   Your responses will be collated with those of other patients and presented to our client in aggregated or anonymous form; your identity will not be revealed.  Your responses will be otherwise confidential and will not be used for any other purposes or disclosed to any third party without your approval.